BMJ Best Practice
最后审核时间: 七月 2019
最近更新时间: 五月 2019

小结

定义

病史和查体

关键诊断因素

  • 存在的危险因素
  • 过分担心,持续至少6个月
  • 焦虑并非源自其他精神障碍
  • 焦虑不是有因使用药物或物质滥用所致

其他诊断因素

  • 头痛
  • 出汗
  • 头晕
  • 胃肠道症状

危险因素

  • 焦虑家族史
  • 躯体或精神压力
  • 躯体或情感创伤史
  • 其他类型焦虑障碍

诊断性检查

需要考虑的检查

  • 甲状腺功能检测
  • 尿液药物筛查
  • 24h尿香草酸及肾上腺素水平测定
  • 肺功能检查 (PFT)
全部具体信息

治疗流程

贡献者

Emeritus Professor Medical Director

Anxiety Treatment and Research Centre

McMaster University and St Joseph’s Hospital

Hamilton

Canada

利益冲突披露
RPS has personally received royalties for articles published in UpToDate (Wolters Kluwer) and the Compendium of Therapeutic Choices, 2nd edition (Canadian Pharmacists Association).

Research Director

Consultant Psychiatrist

Southern District Health Board

Senior Lecturer

Department of Psychological Medicine

Dunedin School of Medicine

Otago University

Dunedin

New Zealand

利益冲突披露
CG is an author of the Royal Australian and New Zealand College of Psychiatrists clinical practice guideline on social phobia, panic disorder, and generalised anxiety disorder. He is a contributor to the Cochrane Common Mental Disorders group, writing on generalised anxiety disorder, and has authored papers relating to heterogeneity of the database separately to Cochrane work. Otago University has commercial and research relationships with multiple pharmaceutical companies. 

Dr Richard P. Swinson and Dr Christopher Gale would like to gratefully acknowledge Dr Elizabeth Hoge and Dr Phebe Tucker, previous contributors to this topic.

利益冲突披露
EH is an author of a number of references cited in this topic. PT has done research for GlaxoSmithKline, Bristol-Myers Squibb, Wyeth Pharmaceuticals, Astra-Zeneca, Cephalon, Inc., and Ortho-McNeil. She has also consulted for Forest Pharmaceuticals and received honoraria from Pfizer, Inc. and Forest Pharmaceuticals.

Research Director

University of Alabama

School of Medicine Tuscaloosa Campus

College of Community Health Sciences

Tuscaloosa

AL

利益冲突披露
LD declares that she has no competing interests.

使用此内容应接受我们的免责声明